Drug discovery

Kuano create superior oncology medicines by adding quantum detail to structure-based drug discovery. The technology fuses state of the art simulation, AI and drug hunting expertise, allowing to illuminate new areas of chemical space.

Be part of SBC Catalyser Programme!

Spaces are limited to 10 companies per cohort. Contact Marco to get more information on our next programme in spring 2024.

Contact Marco

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.